Submitted by Anonymous (not verified) on 24 November 2023 - 13:12
Human medicines European public assessment report (EPAR): Carmustine medac (previously Carmustine Obvius), carmustine, Hodgkin Disease;Lymphoma, Non-Hodgkin, Date of authorisation: 18/07/2018, Revision: 9, Status: Authorised
Source: